Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The TB-YOUTH Study
NCT06022146Phase 3Recruiting
- Sponsor
- Huashan Hospital
- Start
- Sep 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifapentine in Tuberculosis (TB), sponsored by Huashan Hospital. Started Sep 2023; status: recruiting.
02
Drugs
rifapentine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT06022146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06022146.